You just read:

Theravance Biopharma Announces Data from Phase 1b Study of TD-1473 to be Featured in Oral Presentation at Digestive Disease Week (DDW) 2019

News provided by

Theravance Biopharma, Inc.

May 14, 2019, 08:30 ET